SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-004684
Filing Date
2020-02-14
Accepted
2020-02-14 06:02:25
Documents
85
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sbph-10k_20191231.htm 10-K 3596396
2 EX-4.5 sbph-ex45_479.htm EX-4.5 47653
3 EX-21.1 sbph-ex211_242.htm EX-21.1 6220
4 EX-23.1 sbph-ex231_9.htm EX-23.1 2778
5 EX-31.1 sbph-ex311_7.htm EX-31.1 20612
6 EX-31.2 sbph-ex312_6.htm EX-31.2 19656
7 EX-32.1 sbph-ex321_11.htm EX-32.1 9664
  Complete submission text file 0001564590-20-004684.txt   10471278

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT sbph-20191231.xml EX-101.INS 2071756
9 XBRL TAXONOMY EXTENSION SCHEMA sbph-20191231.xsd EX-101.SCH 64163
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20191231_cal.xml EX-101.CAL 73920
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20191231_def.xml EX-101.DEF 214364
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20191231_lab.xml EX-101.LAB 533619
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20191231_pre.xml EX-101.PRE 420906
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37718 | Film No.: 20613483
SIC: 2834 Pharmaceutical Preparations